Risk factors for tubal infertility include pelvic inflammatory disease, history of ectopic pregnancy, history of pelvic abdominal surgery, appendicitis, history of uterine manipulation, and endometriosis. In order to improve the chances of conception, the diagnosis and treatment are addressed through testing. Based on the diagnosis of the results of Hysterosalpinography (HSG) and the degree of tubal patency, the appropriate treatment is chosen. Currently, two minimally invasive methods of treatment are used – “Laparoscopic Surgery” or “Tubal Intervention“.
Among the treatments for infertility caused by tubal factors, tubal intervention has been widely used in clinics as a safe, high success rate, simple and less invasive treatment. Tubal intervention includes: selective salpingography (SSG), Fallopian tube recanalization (FTR), Fallopian tube embolization (FTE).
SSG is a commonly used method to check whether the fallopian tubes are patent or not, to observe the morphology and patency of fallopian tubes by contrast development.SSG is suitable for evaluating whether the fallopian tubes are patent or not, and is commonly used in the initial examination of infertility patients. If the tubes are visualized, the mixture is then injected under pressure, and the tubes are opened by the pushing effect of the hydrostatic pressure of the fluid. If the tubes are not visualized, FTR is performed. Under the guidance of X-ray (C in plate) or ultrasound, the doctor inserts a catheter into the fallopian tube and injects special drugs or instruments through the catheter in order to remove blockages, separate adhesions and unblock the tubes. If unblocking is successful, a contrast agent and mixture are then injected to visualize the patency of the tubes through HSG.
If, based on the diagnosis of HSG, the patient has hydrosalpinx, Fallopian tube embolization (FTE) is indicated. Through interventional means, injection of embolic agents or embolization using devices such as spring coils can effectively block blood and tissue flow in the fallopian tubes, thus treating hydrosalpinx. This procedure is usually performed under X-ray (C in Flat) or ultrasound guidance, which all
ows clear visualization of the fallopian tubes.
The intervention of tubal embolization as a pretreatment for hydrosalpinx is an innovative and proven method. Tubal embolization can be used as an alternative treatment for patients with mild-to-moderate hydrosalpinx who require preservation of the fallopian tubes or who have contraindications to laparoscopic surgery, and all of its operations can be carried out under medical imaging equipment (Flatbed Medium C, ultrasound), with accurate localization and ease of operation. There is no adverse effect on ovarian reserve function and a significant increase in pregnancy rate for IVF.
Perlove medical flat panel in C has a wide application prospect in gynecological interventional therapy, in addition to fallopian tube blockage, it can also be applied to the treatment of a variety of gynecological diseases (ovarian cancer, cervical cancer, uterine fibroids, uterine adenomyosis, post-partum hemorrhage and so on), which can bring better therapeutic effect and health protection for patients.
Shenyang Jinghua Hospital has a high reputation in assisted reproductive technology and is one of the cradles of IVF in the northeast. The hospital has rich experience and expertise in the diagnosis and treatment of infertility, reproductive endocrinology, reproductive health, etc. In March 2023, Shenyang Jinghua Hospital introduced the Perlove Medical Tablet in C and widely used in a variety of surgical procedures, including tubal recanalization and hysteroscopic tubal embolization.
Through the introduction of advanced equipments such as Perlove Medical Tablet C, Shenyang Jinghua Hospital has helped more women retain their uterus, ovaries and fallopian tubes, and improved and restored the ability of natural fertility. With professional technology, excellent service and good medical environment, the hospital provides a safe and reliable diagnosis and treatment platform for the majority of patients.
Large flat panel with wide field of view: 30cm * 30cm large size flat panel detector, which can realize one-time full coverage of the chest, abdomen and pelvis, reduce exposure and radiation, and avoid overlap and omission.